• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 11646

10-year publication summary

378
567
989
1225
1203
1426
1485
1566
1541
678
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
SeaGen Inc
578
248
Daiichi Sankyo Company, Limited
1848
196
Regeneron Pharmaceuticals, Inc.
4201
195
Genentech, Inc.
3927
194
Hanmi Pharm. Co., Ltd.
567
148
MedImmune Limited
605
148
ImmunoGen, Inc.
398
130
Dyne Therapeutics, Inc.
235
124
The Regents of the University of California
19780
114
Bristol-myers Squibb Company
4897
90
Bolt Biotherapeutics, Inc.
119
90
Novartis AG
10975
89
Pfizer Inc.
3355
76
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
278
65
ADC Therapeutics SA
123
62
Hoffmann-La Roche Inc.
3352
60
Memorial Sloan-Kettering Cancer Center
1901
59
CytomX Therapeutics, Inc.
215
58
Hangzhou DAC Biotech Co., Ltd
102
58
Immunomedics, Inc.
267
58
Other owners 9384